Toxoplasma seropositivity and depression: a case report

Kar, Nilamadhab; Misra, Baikunthanath
January 2004
BMC Psychiatry;2004, Vol. 4, p1
Academic Journal
Case Study
Background: The association between toxoplasmosis and psychiatric disorders has been reported in a few anecdotal reports. Case Presentation: A case of depression with toxoplasma seropositivity is presented. The patient with depression showed poor response to antidepressants, for which he was investigated and was found positive on the serological test for the toxoplasma. The response to antidepressant treatment improved only after adequate treatment for toxoplasma. Conclusions: The case suggests a probable association between toxoplasmosis and depression.


Related Articles

  • Depression: How Medicine Can Help.  // American Family Physician;3/1/2000, Vol. 61 Issue 5, special section p1 

    Reveals how medicine can help depression, a mental illness like diabetes or high blood pressure. Causes of depression; Treatment for depression; Things considered by doctor before choosing antidepressant medicine for depressed persons; Different kinds of antidepressants.

  • Repetitive Transcranial Magnetic Stimulation: Does it Have Potential in the Treatment of Depression? Padberg, Frank; Möller, Hans-Jürgen // CNS Drugs;2003, Vol. 17 Issue 6, p383 

    Transcranial magnetic stimulation (TMS) has become a major research tool in experimental clinical neurophysiology as a result of its potential to noninvasively and focally stimulate cortical brain regions. Currently, studies are being conducted to investigate whether repetitive TMS...

  • Antidepressant utilization in Canada. Beck, Cynthia A.; Patten, Scott B.; Williams, Jeanne V. A.; Jian Li Wang; Currie, Shawn R.; Maxwell, Colleen J.; El-Guebaly, Nady; Wang, Jian Li // Social Psychiatry & Psychiatric Epidemiology;Oct2005, Vol. 40 Issue 10, p799 

    Objective: Antidepressant utilization can be used as an indicator of appropriate treatment for major depression. The objective of this study was to characterize antidepressant utilization in Canada, including the relationships of antidepressant use with sociodemographic variables,...

  • Attitudes towards people with mental disorders: the psychometric characteristics of a Finnish questionnaire. Aromaa, Esa; Tolvanen, Asko; Tuulari, Jyrki; Wahlbeck, Kristian // Social Psychiatry & Psychiatric Epidemiology;Feb2010, Vol. 45 Issue 2, p265 

    The prevalence of mental disorders, especially depression, increasingly creates concern for our mental, social and economic well-being. The public has insufficient knowledge about mental disorders and their treatment. A stigma is attached to mental disorders, which has a multifaceted impact on...

  • Review: Antidepressants improve depression in people with Alzheimer's disease. Lyketsos, Constantine G.; Plank Althouse, Elizabeth // Evidence Based Mental Health;Nov2007, Vol. 10 Issue 4, p115 

    The article attempts to determine whether antidepressants are effective and safe for people with depression and Alzheimer's disease. It shows that antidepressants increase response and remission of depressive symptoms compared with placebo in people with Alzheimer's disease and depression when...

  • "Comorbid" Insomnia. Reddy, M. S.; Chakrabarty, Arindam // Indian Journal of Psychological Medicine;Jan-Jun2011, Vol. 33 Issue 1, p1 

    The author focuses on insomnia and its association with several psychiatric disorders. It states that insomnia becomes chronic when it is present for a month or more and chronic insomnia is associated with psychiatric and medical disorders. It mentions that people with depression report insomnia...

  • The Third Category of Mental Disorders. Youxin Xu // Culture, Medicine & Psychiatry;Dec2009, Vol. 33 Issue 4, p496 

    The article discusses the third category of mental disorders which are known as the nonorganic, nonpsychotic mental disorders. Organic mental disorders and psychotic disorders are the other categories of mental disorders. Subcategories of organic mental disorders and psychotic disorders are...

  • Use of a Second Generation Antipsychotic among Patients Diagnosed with Major Depressive Disorder in the United States. Sclar, David A.; Robison, Linda M.; Cohen, Lawrence J.; Laubmeie, Kimberly K.; Kalsekar, Iflekhar D.; Forbes, Robert A. // Pharmaceutical Medicine - New Zealand;2012, Vol. 26 Issue 4, p235 

    Purpose: The purpose of the study was to discern the extent of the prescribing of a second generation atypical antipsychotic (SGA), either alone or in combination with an antidepressant, among patients diagnosed with major depressive disorder (MDD) in the US, and the influence of physician...

  • Economic implications of treatment-resistant depression among employees. Greenberg, Paul; Corey-Lisle, Patricia K.; Birnbaum, Howard; Marynchenko, Maryna; Claxton, Ami // PharmacoEconomics;2004, Vol. 22 Issue 6, p363 

    Background: Conservative estimates indicate between 10% and 20% of all individuals with major depressive disorders (MDDs) fail to respond to conventional antidepressant therapies. Amongst those with MDD, individuals with treatment-resistant depression (TRD) have been found to be...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics